Cedar Grove Capital Management

Cedar Grove Capital Management

Equity Research

SNWV: A Med Devices Co. In Its Early Innings

Why we're bullish on Sanuwave Health, and why a post-Q2 earnings pullback makes for a compelling opportunity to potentially >2x

Paul Cerro's avatar
Paul Cerro
Sep 22, 2025
∙ Paid
Share
Disclaimer: All information provided herein by Cedar Grove Capital Management, LLC (“Cedar Grove Capital” or “the fund”) is for informational purposes only and does not constitute investment advice o…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Paul Cerro
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture